Authors:
Gourdeau, H
Bibeau, L
Ouellet, F
Custeau, D
Bernier, L
Bowlin, T
Citation: H. Gourdeau et al., Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine,BCH-4556) and AraC against leukemic human tumor xenografts expressing highor low cytidine deaminase activity, CANC CHEMOT, 47(3), 2001, pp. 236-240
Authors:
Gourdeau, H
Clarke, ML
Ouellet, F
Mowles, D
Selner, M
Richard, A
Lee, N
Mackey, JR
Young, JD
Jolivet, J
Lafreniere, RG
Cass, CE
Citation: H. Gourdeau et al., Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines, CANCER RES, 61(19), 2001, pp. 7217-7224
Authors:
de Muys, JM
Gourdeau, H
Nguyen-Ba, N
Taylor, DL
Ahmed, PS
Mansour, T
Locas, C
Richard, N
Wainberg, MA
Rando, RF
Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844